Patrick Yachimski1, Chin Hur. 1. Blake 4 Gastrointestinal Unit, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA. pyachimski@partners.org
Abstract
BACKGROUND: The management of patients with acute myocardial infarction (AMI) and upper gastrointestinal bleeding (UGIB) can present a challenge. The utility of upper endoscopy (esophagogastroduodenoscopy, EGD) and endoscopic therapy must be weighed against safety considerations. AIM: To assess the utility and safety of EGD in patients with UGIB and AMI. METHODS: Using decision analysis, patients with UGIB and AMI were assigned to one of two strategies: (1) EGD prior to cardiac catheterization (EGD strategy) and (2) cardiac catheterization without EGD (CATH strategy). RESULTS: In patients with overt UGIB, the EGD strategy resulted in 97 deaths per 10,000 patients, compared with 600 deaths in the CATH strategy. The EGD strategy resulted in fewer non-fatal complications (1,271 vs. 6,000 per 10,000 patients). In patients with occult blood loss, the EGD strategy resulted in more deaths (59 vs. 16 per 10,000) and more non-fatal complications (888 vs. 160 per 10,000) than the CATH strategy. CONCLUSIONS: Our analysis supports EGD prior to cardiac catheterization in patients with AMI and overt UGIB. This strategy results in fewer deaths and complications compared with a strategy of proceeding directly to catheterization. Our analysis does not support routine EGD prior to cardiac catheterization in patients with fecal occult blood.
BACKGROUND: The management of patients with acute myocardial infarction (AMI) and upper gastrointestinal bleeding (UGIB) can present a challenge. The utility of upper endoscopy (esophagogastroduodenoscopy, EGD) and endoscopic therapy must be weighed against safety considerations. AIM: To assess the utility and safety of EGD in patients with UGIB and AMI. METHODS: Using decision analysis, patients with UGIB and AMI were assigned to one of two strategies: (1) EGD prior to cardiac catheterization (EGD strategy) and (2) cardiac catheterization without EGD (CATH strategy). RESULTS: In patients with overt UGIB, the EGD strategy resulted in 97 deaths per 10,000 patients, compared with 600 deaths in the CATH strategy. The EGD strategy resulted in fewer non-fatal complications (1,271 vs. 6,000 per 10,000 patients). In patients with occult blood loss, the EGD strategy resulted in more deaths (59 vs. 16 per 10,000) and more non-fatal complications (888 vs. 160 per 10,000) than the CATH strategy. CONCLUSIONS: Our analysis supports EGD prior to cardiac catheterization in patients with AMI and overt UGIB. This strategy results in fewer deaths and complications compared with a strategy of proceeding directly to catheterization. Our analysis does not support routine EGD prior to cardiac catheterization in patients with fecal occult blood.
Authors: E M Vreeburg; M Levi; E A Rauws; S J Deventer; P Snel; J W Bartelsman; J W Ten Cate; G N Tytgat Journal: Aliment Pharmacol Ther Date: 2001-05 Impact factor: 8.171
Authors: Brian L Bleau; Christopher J Gostout; Kenneth E Sherman; Michael J Shaw; William V Harford; Ray F Keate; Waldo P Bracy; David E Fleischer Journal: Gastrointest Endosc Date: 2002-07 Impact factor: 9.427
Authors: Fahad Al-Ebrahim; Khurram J Khan; Waleed Alhazzani; Ahmed Alnemer; Abdullah Alzahrani; John Marshall; David Armstrong Journal: Can J Gastroenterol Date: 2012-03 Impact factor: 3.522
Authors: Jae Hee Cho; Hee Man Kim; Sangheun Lee; Yu Jin Kim; Ki Jun Han; Hyeon Geun Cho; Si Young Song Journal: World J Gastroenterol Date: 2013-01-07 Impact factor: 5.742
Authors: Ahmed A Elkafrawy; Mohamed Ahmed; Mohammad Alomari; Ahmed Elkaryoni; Kevin F Kennedy; Wendell K Clarkston; Donald R Campbell Journal: World J Clin Cases Date: 2021-02-16 Impact factor: 1.337